RxDoctor Payments Data

Fabien Maldonado, MD

Pulmonary Disease · Nashville, TNNPI 1437161221

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (57.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Medtronic at 41.8% of the total. Reporting peaked in 2020 at $21,356 and has fallen 61.2% since, to $8,281 in 2025. Among pulmonary disease clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$83,346in general payments, 2019–2025

Across 136 payments — averaging $612.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$35K
  • Covidien LP$23K
  • Intuitive Surgical$12K
  • Erbe Elektromedizin GmbH$9K
  • Pleural Dynamics Inc.$2K
  • ERBE USA Inc$678
  • plus $2K from 8 others
$2,377,296in research payments, 2019–2025

Across 39 payments — averaging $60,956 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$1.5M
  • Galvanize Therapeutics, Inc$454K
  • Covidien LP$206K
  • Erbe Elektromedizin GmbH$157K
  • Optellum Ltd$30K
  • Pleural Dynamics Inc.$2K

What the payments were for

  • Consulting fees$8,65410%
  • Speaking & faculty fees$47,84857%
  • Travel & lodging$18,87423%
  • Food & beverage$4,8316%
  • Education$3,0004%
  • Gifts$1400%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$83,346 in reported general payments places this provider in the 95th percentile of 339 pulmonary disease providers in Tennessee.

See all pulmonary disease providers in Tennessee

Medicare billing

Part B allowed, 2024
$59,860
Medicare patients
212
Services billed
524

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →